摘要
通过文献分析以及对比研究方法,总结日本、韩国以及中国台湾地区在罕用药开发方面的激励措施。研究发现,日本对罕用药开发的激励力度最大,韩国和中国台湾地区的激励措施相对保守,但均对罕用药的开发起到了促进作用。通过借鉴其政策实施经验,为制定中国罕用药开发的激励措施提出建议。
Literature review and comparative analysis were employed in this study to summarize the incentivemeasures for facilitating orphan drugs R＆D in Japan, South Korea and Taiwan region of China. It was found that the incentive strength in Japan was the greatest among the countries and region above, while those in South Korea and Taiwan region were relatively conservative. Yet all these incentives had promoted the development of orphan drugs and their successful implementation experience have provide suggestions for the establishment of incentive measures for facilitating orphan drugs R＆D in China.
出处
《中国药科大学学报》
CAS
CSCD
北大核心
2014年第1期125-128,共4页
Journal of China Pharmaceutical University
关键词
罕用药
激励措施
日本
韩国
亚洲
orphan drugs
incentive measures
Japan
South Korea
Asian
